Since the COVID-19 pandemic swept the world in early 2020, many scientists in the viral research community have shifted their focus to study the SARS-CoV-2 coronavirus. Dr. Colleen Jonsson is one of them. She’s the Director of the Regional Biocontainment Laboratory, and Director of the Institute for the Study of Host-Pathogen Systems at the University… Read More
“The goal is to keep people out of the hospital. We are very, very hopeful,” said Dr. Scott Strome, executive dean of the College of Medicine at University of Tennessee Health Science Center. “Our numbers are going through the roof.”
Moderna Inc. is the second pharmaceutical in a week to announce that an independent monitoring board has found its vaccine highly effective against COVID-19. Moderna’s Phase 3 showed 94.5% efficacy. Last Monday, Pfizer’s Phase 3 vaccine showed a 90% success rate in fighting the virus. The FDA has said it would accept vaccines that showed… Read More
Seventeen years ago, Stevie Moore’s son was shot and killed with an assault rifle. On Saturday, Moore stood up in front of a crowd estimated at 420 people, holding a picture of Prentice Moore, his son. “This is my child,” he told the crowd filling the parking lot between Shelby County Juvenile Court and the… Read More
St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center are recruiting adult participants for a phase 3 COVID-19 vaccine clinical trial. More information about the trial, including participant eligibility requirements, is available here. The two are partnering to offer a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s… Read More
St. Jude announced Friday they’re looking for 500 adult participants in a phase three clinical trial of a COVID-19 vaccine. Multiple trials for vaccines and therapies are underway in Memphis right now. St. Jude said a phase three clinical trial of a COVID-19 vaccine with Johnson & Johnson will take place on their campus. Participants… Read More
Mid-South leaders in the medical community are searching for participants for the next phase of the COVID-19 vaccine trial. St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center are offering a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, ENSEMBLE trial.
For months, the $51 million remake of the former Commercial Appeal building has offered the unsettling reassurance that the region has a reservoir if the hospital system gets overwhelmed. On Thursday, leaders at the University of Tennessee Health Science Center, who will be in charge of running it, said they are worried about finding the… Read More
